Bank of America’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $97.1M | Sell |
179,235
-20,191
| -10% | -$11.4M | 0.01% | 1214 |
|
|
2026
Q1 | $118M | Sell |
199,426
-5,705
| -3% | -$2.84M | 0.01% | 1000 |
|
|
2025
Q4 | $100M | Buy |
205,131
+12,287
| +6% | +$5.72M | 0.01% | 1108 |
|
|
2025
Q3 | $80.8M | Sell |
192,844
-19,882
| -9% | -$6.69M | 0.01% | 1347 |
|
|
2025
Q2 | $61.1M | Sell |
212,726
-26,497
| -11% | -$7.92M | ﹤0.01% | 1532 |
|
|
2025
Q1 | $73.7M | Buy |
239,223
+60,146
| +34% | +$20.6M | 0.01% | 1293 |
|
|
2024
Q4 | $63.2M | Buy |
179,077
+11,246
| +7% | +$4.13M | 0.01% | 1315 |
|
|
2024
Q3 | $60.1M | Sell |
167,831
-16,066
| -9% | -$5.43M | ﹤0.01% | 1412 |
|
|
2024
Q2 | $58.6M | Buy |
183,897
+62,381
| +51% | +$16.5M | 0.01% | 1346 |
|
|
2024
Q1 | $27.9M | Buy |
121,516
+48,384
| +66% | +$10.9M | ﹤0.01% | 1966 |
|
|
2023
Q4 | $16.1M | Sell |
73,132
-17,002
| -19% | -$3.92M | ﹤0.01% | 2379 |
|
|
2023
Q3 | $20.4M | Sell |
90,134
-8,734
| -9% | -$2.01M | ﹤0.01% | 2011 |
|
|
2023
Q2 | $21.8M | Sell |
98,868
-18,837
| -16% | -$4.17M | ﹤0.01% | 1954 |
|
|
2023
Q1 | $26.4M | Buy |
117,705
+11,576
| +11% | +$2.85M | ﹤0.01% | 1871 |
|
|
2022
Q4 | $29.5M | Buy |
106,129
+14,729
| +16% | +$3.72M | ﹤0.01% | 1698 |
|
|
2022
Q3 | $19.1M | Sell |
91,400
-149,423
| -62% | -$33.4M | ﹤0.01% | 2005 |
|
|
2022
Q2 | $56.7M | Sell |
240,823
-19,045
| -7% | -$3.87M | 0.01% | 1200 |
|
|
2022
Q1 | $46.6M | Buy |
259,868
+89,836
| +53% | +$17.1M | ﹤0.01% | 1419 |
|
|
2021
Q4 | $36.7M | Sell |
170,032
-14,918
| -8% | -$2.93M | ﹤0.01% | 1647 |
|
|
2021
Q3 | $34.1M | Buy |
184,950
+50,841
| +38% | +$10M | ﹤0.01% | 1643 |
|
|
2021
Q2 | $24.1M | Sell |
134,109
-46,117
| -26% | -$8.78M | ﹤0.01% | 1977 |
|
|
2021
Q1 | $30.1M | Buy |
180,226
+120,458
| +202% | +$20.1M | ﹤0.01% | 1684 |
|
|
2020
Q4 | $9.07M | Sell |
59,768
-91,466
| -60% | -$12M | ﹤0.01% | 2570 |
|
|
2020
Q3 | $15.3M | Buy |
151,234
+38,605
| +34% | +$4.24M | ﹤0.01% | 1929 |
|
|
2020
Q2 | $13.6M | Sell |
112,629
-44,488
| -28% | -$5.01M | ﹤0.01% | 1949 |
|
|
2020
Q1 | $14.9M | Sell |
157,117
-35,984
| -19% | -$3.42M | ﹤0.01% | 1726 |
|
|
2019
Q4 | $17M | Buy |
193,101
+82,925
| +75% | +$7.3M | ﹤0.01% | 2043 |
|
|
2019
Q3 | $8.79M | Buy |
110,176
+7,843
| +8% | +$632K | ﹤0.01% | 2646 |
|
|
2019
Q2 | $7.99M | Sell |
102,333
-36,012
| -26% | -$3.37M | ﹤0.01% | 2794 |
|
|
2019
Q1 | $16.2M | Buy |
138,345
+45,000
| +48% | +$5.24M | ﹤0.01% | 2021 |
|
|
2018
Q4 | $10.2M | Buy |
93,345
+706
| +0.8% | +$81.9K | ﹤0.01% | 2290 |
|
|
2018
Q3 | $11.8M | Sell |
92,639
-7,035
| -7% | -$870K | ﹤0.01% | 2322 |
|
|
2018
Q2 | $11.3M | Buy |
99,674
+2,724
| +3% | +$299K | ﹤0.01% | 2334 |
|
|
2018
Q1 | $10.9M | Sell |
96,950
-3,749
| -4% | -$476K | ﹤0.01% | 2318 |
|
|
2017
Q4 | $14.9M | Sell |
100,699
-9,717
| -9% | -$1.24M | ﹤0.01% | 2075 |
|
|
2017
Q3 | $12.9M | Buy |
110,416
+2,884
| +3% | +$368K | ﹤0.01% | 2252 |
|
|
2017
Q2 | $14M | Buy |
107,532
+42,118
| +64% | +$5.25M | ﹤0.01% | 2057 |
|
|
2017
Q1 | $8.86M | Sell |
65,414
-38,067
| -37% | -$5.77M | ﹤0.01% | 2505 |
|
|
2016
Q4 | $14.8M | Buy |
103,481
+29,598
| +40% | +$3.78M | ﹤0.01% | 1954 |
|
|
2016
Q3 | $8.72M | Sell |
73,883
-55,500
| -43% | -$6.67M | ﹤0.01% | 2357 |
|
|
2016
Q2 | $13.7M | Buy |
129,383
+23,440
| +22% | +$2.61M | ﹤0.01% | 1908 |
|
|
2016
Q1 | $11.8M | Sell |
105,943
-28,035
| -21% | -$3.55M | ﹤0.01% | 2005 |
|
|
2015
Q4 | $21M | Buy |
133,978
+28,032
| +26% | +$4.08M | 0.01% | 1595 |
|
|
2015
Q3 | $13.9M | Buy |
105,946
+62,305
| +143% | +$9.99M | ﹤0.01% | 1919 |
|
|
2015
Q2 | $7.59M | Buy |
43,641
+6,889
| +19% | +$1.24M | ﹤0.01% | 2189 |
|
|
2015
Q1 | $6.34M | Buy |
36,752
+8,115
| +28% | +$1.24M | ﹤0.01% | 2254 |
|
|
2014
Q4 | $3.71M | Sell |
28,637
-30,219
| -51% | -$3.89M | ﹤0.01% | 2825 |
|
|
2014
Q3 | $7.57M | Sell |
58,856
-29,435
| -33% | -$3.03M | ﹤0.01% | 2184 |
|
|
2014
Q2 | $7.81M | Buy |
88,291
+1,468
| +2% | +$141K | ﹤0.01% | 2161 |
|
|
2014
Q1 | $8.16M | Buy |
86,823
+39,860
| +85% | +$4.08M | ﹤0.01% | 1943 |
|
|
2013
Q4 | $5.31M | Sell |
46,963
-39,513
| -46% | -$3.56M | ﹤0.01% | 2426 |
|
|
2013
Q3 | $6.82M | Sell |
86,476
-4,326
| -5% | -$316K | ﹤0.01% | 2130 |
|
|
2013
Q2 | $5.98M | Buy |
+90,802
| New | +$5.85M | ﹤0.01% | 2148 |
|
Other funds holding UTHR
ACA
JT
Bank of America's UTHR Position: Q2 2026 in Review
Bank of America reduced its United Therapeutics (UTHR) stake by 10% in Q2 2026, selling an estimated $11.4M and leaving 179,235 shares worth $97.1M. The position accounts for 0.01% of the portfolio, ranked #1214.
Bank of America first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $118M in Q1 2026. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Bank of America held 179,235 shares of United Therapeutics worth $97.1M as of Q2 2026.
- Bank of America sold 20,191 United Therapeutics shares in Q2 2026, an estimated $11.4M.
- United Therapeutics made up 0.01% of Bank of America's portfolio in Q2 2026, its #1214 holding.
- Bank of America first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Bank of America's United Therapeutics position peaked at $118M in Q1 2026.
- 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.